Source:http://linkedlifedata.com/resource/pubmed/id/16308682
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-4
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0342-4642
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3-5
|
pubmed:meshHeading |
pubmed-meshheading:16308682-Antineoplastic Agents,
pubmed-meshheading:16308682-Critical Illness,
pubmed-meshheading:16308682-Hematologic Neoplasms,
pubmed-meshheading:16308682-Humans,
pubmed-meshheading:16308682-Infusions, Intravenous,
pubmed-meshheading:16308682-Intensive Care,
pubmed-meshheading:16308682-Patient Selection
|
pubmed:year |
2006
|
pubmed:articleTitle |
The intensive care support of patients with malignancy: do everything that can be done.
|
pubmed:publicationType |
Editorial,
Comment
|